We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Biopharma

Biopharma

Stay up to date on the topics that matter to you

Blake Forman profile page

Senior Science Writer

at Technology Networks

Blake pens and edits breaking news, articles and features on a broad range of scientific topics with a focus on drug discovery and biopharma. Blake earned an honors degree in chemistry from the University of Surrey, which involved a placement year at the Medicines and Healthcare products Regulatory Agency (MHRA) laboratory, where he developed new pharmaceutical testing methods. Blake also holds an MSc in chemistry from the University of Southampton. His research project focused on the synthesis of novel fluorescent dyes often used as chemical/bio-sensors and as photosensitizers in photodynamic therapy. Blake held several editorial-based roles before joining Technology Networks in 2024.

Education

University of Surrey

University of Southampton

Areas of Expertise

Mass spectrometry

Pharmacovigilance

Science communication

Analytical chemistry

Got a Question for Blake Forman?

Get in touch using the contact form linked here and we'll get back to you shortly.

Published Content

Total: 107

A researcher holding up a hologram of a molecule in a pill, representing AI-driven anti-infective discovery.

Industry Insight

Anti-Infective Development Boosted by AI and Automation

Anti-infective discovery is evolving with AI and robotics – learn how UK researchers aim to cut development time and improve success rates.

The outside of a US FDA building, which has just announced a hold on new clinical trials sending patient's cells abroad.

FDA To Block Clinical Trials That Send US Patients’ Cells to Foreign Labs

The FDA is reviewing clinical trials that send US patients' cells to foreign labs, citing concerns over genetic data security. Learn more about the new regulations.

A patient talking to a doctor as part of a clinical trial with the words Biomarkers in Focus displayed overhead.

How Digital Biomarkers Enable Patient-Centric Clinical Trials

Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven patient insights.

The front of the White House in America in blue with the words European Pharma React to US Uncertainty overlaid.

European Pharma Experts React to US Tariff Uncertainty

Learn more about the effects US pharmaceutical tariffs could have on European companies and their strategies for overcoming cost and supply chain challenges.

A doctor talking to a cancer patient while they receive cancer therapy via an IV drip.

What’s Next for Cancer Precision Medicine?

Explore the future of precision medicine cancer therapy. Understand personalized treatment strategies and innovations shaping oncology care.

A close up of a syringe drawing COVID-19 vaccine from a vial.

FDA Grants Limited Approval to Moderna’s Next-Gen COVID-19 Vaccine

Moderna’s next-generation COVID-19 vaccine earns FDA approval for high-risk groups only. Learn what this could mean for future COVID-19 vaccine approvals.

A doctor prescribing therapy with a model of a human heart on the desk.

Industry Insight

Are We Close to a Stem Cell Therapy for Heart Failure?

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming next in cardiac care.

A mother helping her young child use an inhalation device to receive cystic fibrosis treatment.

Novel Cystic Fibrosis Treatments Breathe New Life Into the Therapeutic Space

Discover the latest in cystic fibrosis treatment, from CFTR modulators to ENaC blockers and emerging inhalable gene therapies.

A production line of COVID-19 vaccines in vials, representing production of the newly approved Novavax COVID vaccine.

FDA Approves Novavax COVID Vaccine, But With Restrictions

After delays, the FDA has greenlit the Novavax COVID vaccine for targeted groups. Learn more about the approval and what it means for non-mRNA COVID-19 vaccine access.

A white model of a human brain on top of a protein molecule in various colors, representing Parkinson's proteins.

Mitochondrial Mystery of Parkinson’s Protein Solved

Discover how scientists imaged the Parkinson’s protein PINK1, unlocking insight into its role in mitochondrial quality control and brain cell survival.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter